These findings indicate that NRP2 and SHH are expressed at lower levels in IUGR compared to normal conditions, suggesting that a decreased expression of NRP2 and SHH is detrimental to the process of placental vasculogenesis [81]. The gene discussed is NRP2; the disease is fetal growth restriction.